Eraxis

Active Ingredient(s): Anidulafungin
FDA Approved: * February 17, 2006
Pharm Company: * VICURON
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eraxis Overview

Anidulafungin (INN)[1]:42 (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366.[3][4][5] It may also have application in treating invasive Aspergillus infection.[6] It is a member of the class of antifungal drugs known as the echinocandins; its mechanism of action is by inhibition of (1→3)-β-D-glucan synthase, an enzyme important to...

Read more Eraxis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Anidulafungin

Recent Eraxis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Eraxis: (2 results)

Sorted by National Drug Code

• 0049-0114 Eraxis 50 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by Roerig
• 0049-0116 Eraxis 100 mg/30ml Intravenous Injection, Powder, Lyophilized, for Solution by Roerig

Other drugs which contain Anidulafungin or a similar ingredient: (1 result)

• ANIDULAFUNGIN